What Is the Future of the Gastrointestinal Therapeutics Market? Growth Forecasts According to a newly published market research report by 24LifeSciences, global gastrointestinal therapeutics market is valued at USD 35,410 million in 2026 and is projected to reach USD 51,860 million by 2034, growing at a compound annual growth rate (CAGR) of 5.7% during the forecast period. Gastrointestinal therapeutics comprise a critical class of pharmaceuticals designed to treat a wide range of disorders affecting the digestive system, from the esophagus to the colon. This includes prevalent conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and inflammatory bowel disease (IBD). The therapeutic arsenal includes well-established drugs like proton pump inhibitors, biologics, and antacids, commercially available under brands such as Aciphex (rabeprazole) and Prilosec (omeprazole). The sustained efficacy and expanding applications of these treatments continue to underpin their importance in both primary care and specialized gastroenterology practice. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/8881/gastrointestinal-therapeutics-market

Self-Adhesive Labels Market Revenue Forecast, Future Scope, Challenges, Growth Drivers The global self-adhesive labels market is poised for robust growth, projected to expand from USD 48.7 billion in 2025 to USD 84.6 billion by 2033, at a CAGR of 7.3%. These labels—comprising facestock, adhesive, and release liner—are widely used across industries for packaging, branding, and regulatory compliance due to their ease of application and versatility. For more detailed insights, you can explore the full report on https://m2squareconsultancy.com/reports/self-adhesive-labels-market Key growth drivers include the surge in e-commerce, logistics, and demand for packaged consumer goods. Industries such as food & beverages, pharmaceuticals, and cosmetics rely heavily on self-adhesive labels for product information, traceability, and tamper resistance. Technological advancements in printing—especially flexographic and digital methods—have enabled high-quality, customizable designs that enhance brand visibility. Eco-conscious trends are also shaping the market, with manufacturers shifting toward recyclable materials and linerless formats to meet sustainability goals. Asia-Pacific leads the market with over 41% share in 2025, driven by rapid industrialization and retail expansion, while North America is expected to witness the fastest growth due to stringent labeling regulations and demand for smart labeling solutions. Major players like 3M, Avery Dennison, and CCL Industries are investing in RFID-enabled labels and expanding portfolios through strategic acquisitions, reinforcing the market’s dynamic and competitive landscape More Reports Link : https://m2squareconsultancy.com/reports/rare-disease-drugs-market https://m2squareconsultancy.com/reports/sickle-cell-anemia-testing-and-screening-market https://m2squareconsultancy.com/reports/urine-testing-cups-market https://m2squareconsultancy.com/reports/global-vaccines-market https://m2squareconsultancy.com/reports/surgical-instruments-market https://m2squareconsultancy.com/reports/predictive-analytics-market https://m2squareconsultancy.com/reports/smart-cities-market https://m2squareconsultancy.com/reports/seed-treatment-market

#Generic_Drugs are pharmaceutical medicines that contain the same active ingredients, dosage form, strength, safety, and efficacy as brand-name drugs but are sold under their chemical names at lower costs. https://m2squareconsultancy.com/reports/generic-drugs-market #Pharmaceuticals #AffordableMedicine #HealthcareAccess #DrugDevelopment #PharmaIndustry #GenericMedicine #LifeSciences #HealthcareInnovation #PharmaMarket

https://m2squareconsultancy.com/reports/pharmaceuticals-excipients-market